MEDIXAN: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIXAN
Largest movements
- Receivables within one year +€101,661
up €101,661 (+249.1%), from €40,815 to €142,477
of which Trade receivables: +€86,026
- Cash -€29,236
down €29,236 (-12.5%), from €233,394 to €204,157
mainly Receivables within one year (-€101,661) and Investment in fixed assets (net) (-€13,562)
- Tangible fixed assets +€4,382
up €4,382 (+17.1%), from €25,594 to €29,976
of which Other tangible fixed assets: +€9,687
- Reserves +€81,000
up €81,000 (+35.6%), from €227,823 to €308,823
- Other debts -€10,263
down €10,263 (-21.9%), from €46,804 to €36,541
- Tax, wage and social debts +€4,804
up €4,804 (+59.7%), from €8,051 to €12,855
- Gross operating margin +€76,727
up €76,727 (+51.5%), from €149,069 to €225,795
- Financial charges +€19,694
up €19,694 (+25.9%), from €76,054 to €95,747
- Taxes +€15,114
up €15,114 (+61.0%), from €24,770 to €39,884
- Depreciation -€3,733
down €3,733 (-28.9%), from €12,913 to €9,180
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €301,691 | €378,801 | +€77,110 | +25.6% |
| Fixed assets | 21/28 | €25,594 | €29,976 | +€4,382 | +17.1% |
| Tangible fixed assets | 22/27 | €25,594 | €29,976 | +€4,382 | +17.1% |
| Furniture and vehicles | 24 | €9,249 | €3,945 | -€5,305 | -57.4% |
| Other tangible fixed assets | 26 | €16,345 | €26,031 | +€9,687 | +59.3% |
| Current assets | 29/58 | €276,097 | €348,825 | +€72,728 | +26.3% |
| Amounts receivable within one year | 40/41 | €40,815 | €142,477 | +€101,661 | +249.1% |
| Trade receivables | 40 | €29,917 | €115,943 | +€86,026 | +287.5% |
| Other amounts receivable | 41 | €10,898 | €26,534 | +€15,636 | +143.5% |
| Cash at bank and in hand | 54/58 | €233,394 | €204,157 | -€29,236 | -12.5% |
| Deferred charges and accrued income | 490/1 | €1,888 | €2,191 | +€303 | +16.0% |
| Total equity and liabilities | 10/49 | €301,691 | €378,801 | +€77,110 | +25.6% |
| Equity | 10/15 | €242,200 | €323,083 | +€80,883 | +33.4% |
| Contributions | 10/11 | €14,260 | €14,260 | = | 0.0% |
| Reserves | 13 | €227,823 | €308,823 | +€81,000 | +35.6% |
| Distributable reserves | 133 | €227,823 | €308,823 | +€81,000 | +35.6% |
| Profit (loss) carried forward | 14 | €117 | €0 | -€117 | -100.0% |
| Amounts payable | 17/49 | €59,491 | €55,718 | -€3,773 | -6.3% |
| Amounts payable within one year | 42/48 | €59,491 | €55,718 | -€3,773 | -6.3% |
| Trade debts | 44 | €4,635 | €6,321 | +€1,686 | +36.4% |
| Suppliers | 440/4 | €4,635 | €6,321 | +€1,686 | +36.4% |
| Taxes, remuneration and social security | 45 | €8,051 | €12,855 | +€4,804 | +59.7% |
| Taxes | 450/3 | €8,051 | €12,855 | +€4,804 | +59.7% |
| Other amounts payable | 47/48 | €46,804 | €36,541 | -€10,263 | -21.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,913 | €9,180 | -€3,733 | -28.9% |
| Other operating charges | 640/8 | €975 | €1,038 | +€64 | +6.5% |
| Gross operating margin | 9900 | €149,069 | €225,795 | +€76,727 | +51.5% |
| Operating profit (loss) | 9901 | €135,181 | €215,577 | +€80,396 | +59.5% |
| Financial income | 75/76B | €1,423 | €1,823 | +€400 | +28.1% |
| Recurring financial income | 75 | €1,423 | €1,823 | +€400 | +28.1% |
| Financial charges | 65/66B | €76,054 | €95,747 | +€19,694 | +25.9% |
| Recurring financial charges | 65 | €76,054 | €95,747 | +€19,694 | +25.9% |
| Profit (loss) for the period before taxes | 9903 | €60,550 | €121,652 | +€61,102 | +100.9% |
| Income taxes | 67/77 | €24,770 | €39,884 | +€15,114 | +61.0% |
| Profit (loss) for the period | 9904 | €35,781 | €81,769 | +€45,988 | +128.5% |
| Profit (loss) for the period to be appropriated | 9905 | €35,781 | €81,769 | +€45,988 | +128.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.